NCT06525389: Liposomal Amphotericin B and Flucytosine Antifungal Strategy for Talaromycosis (LAmB-FAST)
- State
- Not started
- Phase
- Phase 3
- People
- 428 planned
- Started
- Nov 2026
- Primary completion
- 1 Sep 2030
- Arms
- Liposomal Amphotericin B (LAmB) plus Flucytosine (5FC) placebo
- Results
- None posted
- 29 Jul 2024: Trial registered